Ilan Oren
Chair of the BoardatRoivant Sciences· In proxies 2022–2024
Ilan Oren sits on 6 public boards.
Boards1
- Roivant SciencesChair · 10 yr on the boardIndependentCompensation, Nominating and Governance (Chair)—Paid as an executive
%20scale(0.100000,-0.100000)'%20fill='%23000000'%20stroke='none'%3e%3cpath%20d='M3195%205489%20c-380%20-49%20-706%20-317%20-831%20-682%20-56%20-163%20-54%20-112%20-54%20-1773%20l0%20-1534%20590%200%20590%200%200%201465%200%201465%20600%200%20600%200%200%20535%200%20535%20-712%20-1%20c-392%20-1%20-744%20-6%20-783%20-10z'/%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Roivant SciencesPublic company · 4 yr
- Chair of the Board2022 – Present · 4 yrStock in role +356%
- Clexio BiosciencesPublic company
- Director? – PresentNo stock prices for these years
- Dexxon HoldingsPublic company
- Director? – PresentNo stock prices for these years
- Kriya TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Cynapsus TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Sio Gene TherapiesPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?